Cassandra Brown
Nurse Practitioner · Oregon, OHNPI 1992366546
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 62.6% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2024 at $8,943 and has fallen 91.7% since, to $747 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $75.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$10K
- Abbott$2K
- Medtronic$1K
- Spinal Simplicity, LLC$635
- Relievant Medsystems, Inc.$443
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$383
- plus $2K from 23 others
What the payments were for
- Consulting fees$1,2508%
- Speaking & faculty fees$6,00037%
- Travel & lodging$3,68323%
- Food & beverage$5,05532%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 53 | $10,028 |
| Abbott | 7 | $1,696 |
| Medtronic | 22 | $1,290 |
| Spinal Simplicity, LLC | 10 | $635 |
| Relievant Medsystems, Inc. | 3 | $443 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 47 | $383 |
| Boston Scientific | 12 | $252 |
| Globus Medical | 14 | $223 |
| Vertos Medical, Inc. | 1 | $164 |
| AbbVie(2 entities) | 7 | $156 |
| MML US, Inc. | 2 | $155 |
| Nalu Medical, Inc. | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Merz Pharmaceuticals, LLC | 3 | $52 |
| Pfizer | 3 | $49 |
| Almatica Pharma LLC | 3 | $46 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Bioventus LLC | 2 | $39 |
| GRT US Holding, Inc. | 2 | $39 |
| Masimo Corporation | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Roche Diagnostics Corporation | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Vertex | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Painteq LLC | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$6,183
- Omnia$3,035
- Axium$1,648
- Intracept$1,165
- INTELLIS ADAPTIVESTIM$878
- HA MINUTEMAN G3-R$398
- mild Device Kit$164
- INCEPTIV$151
- ReActiv8$142
How this compares
$16,012 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 45 | $42,468 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,145 | $27,601 |
| NucyntaTapentadol Hcl | 22 | $26,747 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 692 | $13,514 |
| GraliseGabapentin | 17 | $10,948 |
| Gabapentin | 677 | $7,725 |
| MovantikNaloxegol Oxalate | 11 | $7,033 |
| Pregabalin | 219 | $6,909 |
| Buprenorphine | 28 | $5,848 |
| Lidocaine | 73 | $5,095 |
| Oxycodone Hcl | 274 | $5,053 |
| Fentanyl | 45 | $3,948 |
| Morphine Sulfate ErMorphine Sulfate | 98 | $1,648 |
| Tramadol Hcl | 197 | $1,239 |
| Tizanidine Hcl | 183 | $1,204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta | $64 | $69,21567 claims |
| Almatica Pharma LLCGralise | $46 | $10,94817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Oregon
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.